Nutraceuticals for the management of conditions related to type 2 diabetes

Abstract

Disclosed are nutraceutical formulations, including extracts comprising the hydrophilic and lipophilic fractions of stabilized rice bran. Also disclosed are methods for using said nutraceutical formulations for the management or remediation of conditions related to type II diabetes in humans, including methods for decreasing HbA1c and fasting glucose blood concentrations, and for increasing serum fasting insulin levels.

1 . A method of managing chronic health conditions related to type II diabetes, said method comprising the administration of a nutraceutical in an amount sufficient to decrease HbA1c blood concentrations in type II diabetic patients, said stabilized rice bran extract nutraceutical comprising a hydrophilic soluble fraction/lipophilic fiber fraction ratio of about 1.0 to about 1.5. 
     
     
         2 . A method of managing chronic health conditions related to type II diabetes, said method comprising the administration of a nutraceutical in an amount sufficient to reduce the fasting glucose concentration in blood, said stabilized rice bran extract nutraceutical comprising a hydrophilic soluble fraction/lipophilic fiber fraction ratio of about 1.0 to about 1.5. 
     
     
         3 . A method of managing chronic health conditions related to type II diabetes, said method comprising the administration of a nutraceutical in an amount sufficient to increase the serum fasting insulin levels, said stabilized rice bran extract nutraceutical comprising a hydrophilic soluble fraction/lipophilic fiber fraction ratio of about 1.0 to about 1.5.